These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 20432461)
1. Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity. Kozloski GA; Carraway CA; Carraway KL J Cell Physiol; 2010 Sep; 224(3):649-57. PubMed ID: 20432461 [TBL] [Abstract][Full Text] [Related]
2. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury. Theodoropoulos G; Carraway CA; Carraway KL J Cell Biochem; 2009 May; 107(1):112-22. PubMed ID: 19288496 [TBL] [Abstract][Full Text] [Related]
3. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Workman HC; Sweeney C; Carraway KL Cancer Res; 2009 Apr; 69(7):2845-52. PubMed ID: 19293191 [TBL] [Abstract][Full Text] [Related]
4. Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. Ramsauer VP; Pino V; Farooq A; Carothers Carraway CA; Salas PJ; Carraway KL Mol Biol Cell; 2006 Jul; 17(7):2931-41. PubMed ID: 16624867 [TBL] [Abstract][Full Text] [Related]
5. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Jepson S; Komatsu M; Haq B; Arango ME; Huang D; Carraway CA; Carraway KL Oncogene; 2002 Oct; 21(49):7524-32. PubMed ID: 12386815 [TBL] [Abstract][Full Text] [Related]
6. Muc4/MUC4 functions and regulation in cancer. Carraway KL; Theodoropoulos G; Kozloski GA; Carothers Carraway CA Future Oncol; 2009 Dec; 5(10):1631-40. PubMed ID: 20001800 [TBL] [Abstract][Full Text] [Related]
7. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines. Yokoyama A; Shi BH; Kawai T; Konishi H; Andoh R; Tachikawa H; Ihara S; Fukui Y Biochem Biophys Res Commun; 2007 Mar; 355(1):200-3. PubMed ID: 17292332 [TBL] [Abstract][Full Text] [Related]
8. The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. Funes M; Miller JK; Lai C; Carraway KL; Sweeney C J Biol Chem; 2006 Jul; 281(28):19310-9. PubMed ID: 16690615 [TBL] [Abstract][Full Text] [Related]
9. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. Arango ME; Li P; Komatsu M; Montes C; Carraway CA; Carraway KL Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2749-56. PubMed ID: 11687512 [TBL] [Abstract][Full Text] [Related]
10. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Holbro T; Beerli RR; Maurer F; Koziczak M; Barbas CF; Hynes NE Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8933-8. PubMed ID: 12853564 [TBL] [Abstract][Full Text] [Related]
11. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2. Kawano S; Ikeda W; Kishimoto M; Ogita H; Takai Y J Biol Chem; 2009 Aug; 284(35):23793-805. PubMed ID: 19561085 [TBL] [Abstract][Full Text] [Related]
15. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116 [TBL] [Abstract][Full Text] [Related]
16. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875 [TBL] [Abstract][Full Text] [Related]
17. Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3. Sak MM; Szymanska M; Bertelsen V; Hasmann M; Madshus IH; Stang E Carcinogenesis; 2013 Sep; 34(9):2031-8. PubMed ID: 23698633 [TBL] [Abstract][Full Text] [Related]
18. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Price-Schiavi SA; Jepson S; Li P; Arango M; Rudland PS; Yee L; Carraway KL Int J Cancer; 2002 Jun; 99(6):783-91. PubMed ID: 12115478 [TBL] [Abstract][Full Text] [Related]
19. Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: potential pathobiological implications. Miyahara N; Shoda J; Kawamoto T; Ishida H; Ueda T; Akimoto Y; Kawakami H; Irimura T Oncol Rep; 2014 Nov; 32(5):1796-802. PubMed ID: 25174601 [TBL] [Abstract][Full Text] [Related]
20. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling. Zhang Q; Park E; Kani K; Landgraf R Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]